about
Regular self-examination or clinical examination for early detection of breast cancerDeficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joiningPerspectives on the chemical etiology of breast cancer.Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: Evidence for genetic susceptibilityChromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features.Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expressionTumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines.Methylenetetrahydrofolate Reductase A1298C Polymorphism and Breast Cancer Risk: A Meta-analysis of 33 StudiesLow expression of bcl-2 in Brca1-associated breast cancersMedical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance.Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations.Stromal adipocyte PPARγ protects against breast tumorigenesis.Associations between ALDH1A1 polymorphisms, alcohol consumption, and mortality among Hispanic and non-Hispanic white women diagnosed with breast cancer: the Breast Cancer Health Disparities Study.
P2860
Q24248690-5B602F51-910E-4191-9D73-EF4EFD38E5D2Q24630418-0AB61D03-E247-4703-AACC-A09BE66774E4Q24811790-626E0221-B936-4726-B942-EF986D8BE921Q26775398-92C707C8-5F66-4FCA-B92D-4CCB17A526E5Q28360494-A963F496-3C09-476E-8F37-C570E1BE1A38Q28771498-1E0B9BCB-2150-40A1-B4A6-11F8138AA130Q34109373-96B65EAF-540D-43F3-8439-F158536AEA9DQ34480612-059830B8-827D-416E-A8BD-35B6D544CB1DQ34606679-6A441346-92CB-4C89-891F-025C8492E1B8Q36691973-E8BD1BDE-C190-49A2-91BD-E7887EE4366CQ37040747-E045AED5-98AE-43FE-BC0A-75F26158A201Q37137877-A55E4CB3-E0A9-4801-B755-07B4ECED8A6DQ37363083-C24689B1-28EF-49AC-877F-BDC76D1C42A3Q43566087-ADC109B6-D352-4DC9-B1BB-8E3AFA88D768Q46409708-0CACA9A1-2E13-4641-807C-F4F1413D49CA
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
BRCA1 and BRCA2 in breast cancer.
@ast
BRCA1 and BRCA2 in breast cancer.
@en
type
label
BRCA1 and BRCA2 in breast cancer.
@ast
BRCA1 and BRCA2 in breast cancer.
@en
prefLabel
BRCA1 and BRCA2 in breast cancer.
@ast
BRCA1 and BRCA2 in breast cancer.
@en
P2860
P356
P1476
BRCA1 and BRCA2 in breast cancer.
@en
P2093
P2860
P2888
P356
10.1023/A:1006189906896
P407
P577
1999-03-01T00:00:00Z
P6179
1024719710